Microbiome-Based Therapeutics: Emerging Trends in Health Biotechnology

Recent technological advancements have allowed for a thorough examination of the human microbiome, leading to the discovery of certain microbial patterns that are linked to health and disease. This validates the essential function of bacteria in preserving homeostasis and the overall health condition of the host. In this review, we thoroughly analyze the present state of microbiome-based medicines, including established and developing techniques. We explore the mechanisms of action of these therapies, their applications, and the associated problems. In addition, we outline the challenges faced by the scientific community in the advancement of microbiome therapeutics. Investigations into the human gut microbiome have expanded our knowledge of how microorganisms establish, develop, and become imbalanced in different states of health. Microbiome therapies include manipulating the gut microbiome by using various treatments, such as adding, removing, or modifying the bacteria. This may be done using natural or modified microorganisms, antibiotics, bacteriophages, and bacteriocins. This strategy has the potential to surpass the restrictions of traditional treatments by offering individualized, coordinated, dependable, and enduring therapy. Although promising, microbiome therapies are still in the early stages of development and face many technical and administrative challenges. These challenges include optimizing microbial therapies for specific body parts, identifying appropriate biosensors, establishing the resilience of engineered synthetic gene circuits, and addressing biosafety concerns.